We are live on ! Find out more
Thrivent Financial for Lutherans

Thrivent Financial for Lutherans Portfolio holdings

AUM $52.5B
1-Year Est. Return 27.12%
This Fund
S&P 500
This Quarter Est. Return
-2.28%
1 Year Est. Return
+27.12%
3 Year Est. Return
+79.38%
5 Year Est. Return
+100.59%
10 Year Est. Return
+446.23%
AUM
$42.1B
AUM Growth
-$1.72B
Cap. Flow
-$197M
Cap. Flow %
-0.47%
Top 10 Hldgs %
13.45%
Holding
2,546
New
90
Increased
772
Reduced
1,435
Closed
118

Top Buys

Rank Stock Value
1
SBAC icon
SBA Communications
SBAC
+$152M
2
NI icon
NiSource
NI
+$122M
3
ENPH icon
Enphase Energy
ENPH
+$83.5M
4
FDS icon
Factset
FDS
+$79.3M
5
AXON
Axon Enterprise
AXON
+$75M

Top Sells

Rank Stock Value
1
FWRD icon
Forward Air
FWRD
+$137M
2
ETR icon
Entergy
ETR
+$118M
3
SPGI icon
S&P Global
SPGI
+$118M
4
PODD icon
Insulet
PODD
+$96.1M
5
DLR icon
Digital Realty Trust
DLR
+$91.6M

Sector Composition

Rank Sector Weight
1 Technology 17.23%
2 Financials 12.43%
3 Industrials 10.88%
4 Healthcare 10.7%
5 Consumer Discretionary 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPM icon
2351
Evolution Petroleum
EPM
$131M
$74K ﹤0.01%
10,753
DSKE
2352
DELISTED
Daseke, Inc. Common Stock
DSKE
$72K ﹤0.01%
14,017
BTAI icon
2353
BioXcel Therapeutics
BTAI
$27.8M
$50K ﹤0.01%
1,250
+625
+100% +$63.2K
OPK icon
2354
Opko Health
OPK
$1.02B
$45K ﹤0.01%
30,000
GSAT icon
2355
Globalstar
GSAT
$10.8B
$26K ﹤0.01%
1,344
LCTX icon
2356
Lineage Cell Therapeutics
LCTX
$278M
$18K ﹤0.01%
15,000
CATX icon
2357
Perspective Therapeutics
CATX
$342M
$11K ﹤0.01%
4,000
INO icon
2358
Inovio Pharmaceuticals
INO
$69M
$8K ﹤0.01%
1,667
OCGN icon
2359
Ocugen
OCGN
$434M
$8K ﹤0.01%
20,000
WKHS icon
2360
Workhorse Group
WKHS
$36.3M
$6K ﹤0.01%
4
ZOM
2361
DELISTED
Zomedica Corp.
ZOM
$4K ﹤0.01%
20,925
ADPT icon
2362
Adaptive Biotechnologies
ADPT
$3.97B
-42,435
Closed -$285K
ALLO icon
2363
Allogene Therapeutics
ALLO
$694M
-129,535
Closed -$644K
ANGO icon
2364
AngioDynamics
ANGO
$649M
-37,534
Closed -$391K
ARRY icon
2365
Array Technologies
ARRY
$855M
-27,336
Closed -$618K
ATKR icon
2366
Atkore
ATKR
$3.16B
-9,663
Closed -$1.51M
AU icon
2367
AngloGold Ashanti
AU
$48.7B
-42,332
Closed -$892K
BCE icon
2368
BCE
BCE
$21.2B
-5,256
Closed -$237K
BHC icon
2369
Bausch Health
BHC
$2.34B
-63,181
Closed -$506K
BMRN icon
2370
BioMarin Pharmaceuticals
BMRN
$12.4B
-2,393
Closed -$207K
BZ icon
2371
Kanzhun
BZ
$7.36B
-28,094
Closed -$423K
CHRS icon
2372
Coherus Oncology
CHRS
$196M
-63,960
Closed -$273K
CHWY icon
2373
Chewy
CHWY
$9.63B
-14,573
Closed -$575K
CHY
2374
Calamos Convertible and High Income Fund
CHY
$1.06B
-11,603
Closed -$130K
CLNE icon
2375
Clean Energy Fuels
CLNE
$346M
-111,054
Closed -$551K

Similar funds

Thrivent Financial for Lutherans's Q3 2023 Portfolio in Review

As of Q3 2023, Thrivent Financial for Lutherans held 2,546 positions worth $42.1B, down 3.9% from $43.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Thrivent Financial for Lutherans's Q3 2023 filing shows 90 new, 772 increased, 1,435 reduced and 118 closed positions. Its largest new stake was Kenvue: 2,254,203 shares worth $45.3M. The largest sale was Forward Air, an estimated $137M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Industrials.

  • Thrivent Financial for Lutherans's largest Q3 2023 buy was Kenvue: 2,254,203 shares worth $45.3M.
  • Thrivent Financial for Lutherans added most to SBA Communications in Q3 2023, an estimated $152M increase.
  • Thrivent Financial for Lutherans's biggest Q3 2023 reduction was Forward Air, cutting an estimated $137M.
  • Thrivent Financial for Lutherans fully exited Ionis Pharmaceuticals in Q3 2023, selling an estimated $40.5M.
  • Thrivent Financial for Lutherans's ten largest holdings make up 13% of its $42.1B portfolio in Q3 2023.
  • Thrivent Financial for Lutherans opened 90 new positions and closed 118 in Q3 2023.
  • Thrivent Financial for Lutherans's portfolio value fell 3.9% quarter-over-quarter to $42.1B.

Based on Thrivent Financial for Lutherans's 13F filing for Q3 2023, filed 14 Nov 2023.